Safety and Efficacy of a Single Subretinal Injection of JWK002 Gene Therapy in Subjects With X-linked Retinoschisis(XLRS)
NCT06345898
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
12
Enrollment
OTHER
Sponsor class
Conditions
X Linked Retinoschisis
Interventions
DRUG:
JWK002
Sponsor
West China Hospital